Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,288 total articles
Entities linked to Silver Lake and Dell Technologies Inc. (NYSE:DELL) director Egon Durban executed a sale of 600 shares of Dell Technologies Class C Common Stock on July 9, 2026, generating $272,578 in proceeds. The divestment follows a conversion of Class B shares into Class C shares and occurs amidst a 260% stock surge over the past six months. …
Entities tied to Silver Lake, including Dell director Egon Durban, executed a $31.1 million sale of Dell Technologies Inc. (NASDAQ:DELL) Class C Common Stock on July 9, 2026. The transactions followed a structural conversion of Class B shares into Class C, highlighting ongoing capital adjustments within the firm's holdings. This activity occurs aga…
Juan C. Jaen, President of Arcus Biosciences (NASDAQ:RCUS), completed the sale of 68,569 shares over two days in July 2026, generating approximately $2.03 million. The transactions were executed via a Rule 10b5-1 trading plan, a mechanism designed to allow insiders to trade shares according to a predetermined schedule. This activity follows a signi…
Charles H Giancarlo, serving as both Chief Executive Officer and a board director at Everpure, Inc. (NASDAQ:P), has completed a series of equity transactions totaling approximately $10.9 million. The divestitures occurred across two consecutive trading days in early July 2026, with shares changing hands at prices between $80.00 and $82.50. All sale…
Windacre Partnership Master Fund, LP, a significant institutional investor in Perimeter Solutions, Inc. (NASDAQ: PRM), has executed a substantial divestment of its holdings in the fire retardant manufacturer. The fund sold approximately $195.6 million worth of ordinary shares between June 26 and June 30, 2026. This transaction occurs as the stock h…
Director Susan J.S. Taylor executed a significant equity sale in Everpure, Inc. (NASDAQ:P) on July 9, 2026, divesting 8,543 shares at $81.74 per share. The transaction, valued at $698,304, occurs as the stock trades below the sale price, reflecting a complex dynamic between insider activity and broader market valuation metrics. This move follows a …
Neil Almstead, PTC Therapeutics' Chief Technical Operations Officer, executed a series of transactions on July 9, 2026, involving the exercise of stock options and the subsequent sale of 2,464 shares. The transactions were conducted under a Rule 10b5-1 plan established in November 2025. The sale occurred as the stock traded near its 52-week high, w…
PTC Therapeutics director Mary L. Smith executed a series of transactions on July 9, 2026, selling 15,834 shares valued at approximately $1.43 million. The sales followed the exercise of stock options on the same date, all conducted under a pre-arranged Rule 10b5-1 trading plan established in November 2025. This activity occurs against a backdrop o…
Kevin J. Mitchell, Executive Vice President and Chief Financial Officer at Phillips 66 (NYSE: PSX), executed a significant stock transaction on July 9, 2026, selling 11,021 shares for a total value of $2,094,285. The sale was facilitated through the exercise of employee stock options, which were granted under a vesting schedule that began on Februa…
Arjun Agarwal, Senior Vice President of Finance at Oruka Therapeutics, Inc. (NASDAQ: ORKA), executed a significant sale of company stock on July 13, 2026, following the exercise of employee stock options on the same day. The transactions occurred as the biotech firm's shares trade near a 52-week high, reflecting a substantial one-year gain, while a…
Ryan Savitz, Executive Vice President, Chief Financial Officer, and Chief Business Officer of Dianthus Therapeutics, Inc. (NASDAQ:DNTH), executed a series of transactions involving the sale of 31,249 shares of common stock on July 9, 2026, totaling approximately $3.16 million. The sales were conducted under a Rule 10b5-1 trading plan adopted on Dec…
Todd Dzyak, Chief Operating Officer of WidePoint Corporation, executed a sale of 5,000 shares of the company's common stock on July 9, 2026. The transaction was valued at $63,750, with each share sold at $12.75. This divestment reduces Dzyak's direct holdings to 110,436 shares. The sale comes as WidePoint reports improved Q1 2026 financial results,…
Michael George Rosenbaum, Chief Executive Officer of Guidewire Software, Inc. (NASDAQ:GWRE), sold 1,200 shares of the company's common stock on July 13, 2026. The transaction, valued at $166,164, was executed automatically under a 10b5-1 trading plan adopted on October 14, 2025. Following the sale, Rosenbaum directly holds 194,976 shares. The sale …
BridgeBio Pharma, Inc. (NASDAQ: BBIO) director Andrea Ellis executed a sale of $1,442,028 in company stock on July 9, 2026. The transaction, covering 17,167 shares at $84.00 per share, was conducted under a pre-established Rule 10b5-1 plan adopted in December 2025. This sale coincides with a period of significant corporate activity for BridgeBio, i…
Richard McCathron, Chief Executive Officer of Hippo Holdings Inc. (NASDAQ: HIPO), executed a sale of 5,000 shares of common stock on July 9, 2026, generating proceeds of $142,650. The transaction, priced at $28.53 per share, was conducted under a Rule 10b5-1 trading plan established on August 29, 2025. Following the sale, McCathron retains a direct…
Wilfred T. O’Gara, a director at LSI Industries Inc. (NASDAQ:LYTS), executed a significant divestment of 10,369 common shares on June 1, 2026, realizing approximately $249,789. This transaction reduces his direct holdings, including a joint account with his spouse, to 103,686 shares. The sale occurs against a backdrop of strong operational performa…
Jennifer E. Cook, a director at BridgeBio Pharma, Inc. (NASDAQ: BBIO), executed a series of complex transactions on July 9, 2026, involving the sale and acquisition of company stock. The director sold 148,589 shares valued at approximately $13.16 million under a Rule 10b5-1 plan, while simultaneously acquiring an equal number of shares through stoc…
Oguzhan Atay, Chairman and Chief Executive Officer of BillionToOne, Inc. (NASDAQ:BLLN), executed a sale of 12,500 shares of Class A Common Stock on July 9, 2026, realizing approximately $1.57 million in proceeds. The transactions were facilitated through a pre-existing Rule 10b5-1 trading plan established in March 2026. Despite the executive divest…
A consortium of reporting owners, including Aqua Capital, Ltd. and Durango Capital, Ltd., has acquired 60,000 shares of Energizer Holdings, Inc. (NASDAQ: ENR) for approximately $1.23 million. The transactions, executed on July 9 and July 10, 2026, bring the group's direct and indirect ownership to 7,480,000 shares, solidifying their status as a gre…
BillionToOne, Inc. (NASDAQ:BLLN) Chief Product Officer Sakakibara Shan Riku completed a $1,000,000 sale of 8,000 Class A Common Stock shares on July 9, 2026. The transaction, executed at $125 per share, was facilitated through a Rule 10b5-1 trading plan established on March 6, 2026. Concurrently, Sakakibara exercised fully vested stock options to a…
Datadog, Inc. (NASDAQ:DDOG) director Amit Agarwal has executed a significant sale of Class A Common Stock shares. The transaction, valued at approximately $5.35 million, was carried out through a pre-arranged trading plan. This activity occurs as the company faces contrasting analyst outlooks and continues its strategic focus on artificial intellig…
David A. Duffield, a principal 10% shareholder of Workday Inc., offloaded 107,500 Class A Common Stock shares on July 9, 2026, generating approximately $14.7 million in proceeds. The transaction, facilitated through a Rule 10b5-1 trading plan linked to a 2025 trust arrangement, involved converting an equal number of Class B shares prior to sale. Th…
Darin Lippoldt, the Chief Legal Officer at Neurocrine Biosciences Inc. (NASDAQ: NBIX), executed a sale of 10,000 shares of the company's common stock on July 9, 2026, totaling approximately $1.79 million. The transaction was conducted under a Rule 10b5-1 trading plan established prior to the sale. This activity occurs as the company navigates a per…
Grace & Mercy Foundation, Inc. has increased its direct ownership in Gloo Holdings, Inc. (NASDAQ:GLOO) through a recent purchase of Class A Common Stock. The transaction, executed as part of a broader firm commitment underwritten public offering, underscores the foundation's continued capital allocation into the company. This activity occurs agains…
Ooma Inc. CEO Eric Stang executed a direct sale of company stock in July, while the firm recently delivered fiscal 2027 first-quarter results that beat consensus estimates on earnings, revenue, and EBITDA. Following these financial beats, management raised its full-year outlook, and multiple investment firms adjusted their price targets upward or r…
